These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7032541)

  • 1. [Cell wall skeletons of Candida albicans and micrococci as antitumor immunoadjuvants].
    Favalli C; Baccarini M; Blasi E; Bevilacqua R; Rinaldi C; Mastroviti F
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1911-5. PubMed ID: 7032541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitumor activity of bacterial fractions and related synthetic compounds].
    Azuma I; Yamamura Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2691-9. PubMed ID: 6508322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor immunoadjuvants of microbial origin: the limitations in the immune system and microbial structure].
    Cassone A
    Ann Ist Super Sanita; 1982; 18(3):497-500. PubMed ID: 6765082
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific and nonspecific immunomodulation by wall components of Candida albicans.
    Domer JE
    J Chemother; 1989 Jul; 1(4 Suppl):441-3. PubMed ID: 16312478
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomodulation by inactivated Candida albicans].
    Bistoni F; Marconi P; Cassone A; Frati L
    G Ital Chemioter; 1985; 32(1):147-52. PubMed ID: 3913614
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo antigen expression of Candida albicans.
    Cutler JE; Brawner DL; Zanotti RM; Glee PM; Li RK
    J Chemother; 1989 Jul; 1(4 Suppl):443-5. PubMed ID: 16315373
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of macrophage phagocytic activity by cell wall components of Candida albicans.
    Szabo I; Guan L; Rogers TJ
    Cell Immunol; 1995 Sep; 164(2):182-8. PubMed ID: 7656326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial cell walls, innate immunity and immunoadjuvants.
    Strominger JL
    Nat Immunol; 2007 Dec; 8(12):1269-71. PubMed ID: 18026075
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall.
    Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P
    Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.
    Cassone A; Bistoni F; Cenci E; Pesce CD; Tissi L; Marconi P
    Sabouraudia; 1982 Jun; 20(2):115-25. PubMed ID: 7051368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of the monoclonal antibody 3H8 in the immunohistochemical identification of Candida species.
    Järvensivu A; Rautemaa R; Sorsa T; Richardson M
    Oral Dis; 2006 Jul; 12(4):428-33. PubMed ID: 16792731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic variability of Candida albicans cell surface.
    Cutler JE; Kanbe T
    Curr Top Med Mycol; 1993; 5():27-47. PubMed ID: 8242804
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E
    Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
    Marconi P; Cassone A; Tissi L; Baccarini M; Puccetti P; Garaci E; Bonmassar E; Bistoni F
    Int J Cancer; 1982 Apr; 29(4):483-8. PubMed ID: 7044994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice.
    Martínez-López R; Nombela C; Diez-Orejas R; Monteoliva L; Gil C
    Proteomics; 2008 Jul; 8(13):2651-64. PubMed ID: 18546157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of culture conditions on vasculitis and anaphylactoid shock induced by fungal pathogen Candida albicans cell wall extract in mice.
    Tada R; Nagi-Miura N; Adachi Y; Ohno N
    Microb Pathog; 2008 May; 44(5):379-88. PubMed ID: 18065191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant activity of Bacterionema matruchotii.
    Takazoe I; Okuda K; Ohta K
    Bull Tokyo Dent Coll; 1978 Feb; 19(1):13-7. PubMed ID: 292523
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody response to Candida albicans cell wall antigens.
    López-Ribot JL; Casanova M; Murgui A; Martínez JP
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):187-96. PubMed ID: 15196567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-mediated inhibition of adhesion of Candida albicans and Candida dubliniensis to human epithelial cells.
    Elguezabal N; Maza JL; Moragues MD; Pontón J
    Eur J Oral Sci; 2009 Aug; 117(4):474-8. PubMed ID: 19627362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.